You have no items in your shopping cart.
On Promotion
Species Host
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 440Biotin 62FITC 58PE 56APC 49HRP 32Cy3 19PE/Cy5 19PerCP 19PE/Cy7 18PE/Cy5.5 13Pacific Blue 13PerCP/Cy5.5 13APC/Cy7 12Carrier-free 12Fluoro488 12Fluoro550 12Fluoro594 12Fluoro647 12APC/Cy5.5 10BF405 10BF488 10BF647 10BF700 10Cy5 10PerCP/Cy7 10BF350 9BF555 9BF594 9BF680 9BF750 9Cy5.5 9Cy7 9RBITC 9AP 8IRDye800 7ALP 6PE/Texas Red 2RPE 2AE 1Elab Fluor Red 780 1Elab Fluor Violet 450 1PF488P 1PF647P 1SureLight 488 1Tri-Color 1mFV450 1mFV540 1
Biologically Active
Featured Product
Search results for: 'IL-2'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.5 KDa. Observed: 40-60 KDa, reducing conditions
Mouse
Glu22-Lys236
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.6 KDa. Observed: 60-90 KDa, reducing conditions
Mouse
Glu22-Lys236
C-Fc
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 51.7 KDa. Observed: 60-80 KDa, reducing conditions
Human
Ala27-Asp239
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SEC-HPLC: Greater than 90% as determined by SEC-HPLC.(QC verified)
Predicted: 25.6 KDa. Observed: 35-40 KDa, reducing conditions
Human
Ala27-Asp239
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 90% as determined by SEC-HPLC. (QC verified)
Predicted: 48.9 KDa. Observed: 60-80 KDa, reducing conditions
Human
Glu22-Cys213
C-Fc
50 μg, 10 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 22.8 KDa. Observed: 35-44 KDa, reducing conditions
Human
Glu22-Cys213
C-6His
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 48.6 KDa. Observed: 65-75 KDa, reducing conditions
Cynomolgus
Glu22-Arg213
C-Fc
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 24.6 KDa. Observed: 33-55 KDa, reducing conditions
Human
Glu22-Cys213
C-6His-Avi
100 μg, 20 μgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 22.5 KDa. Observed: 28-48 KDa, reducing conditions
Cynomolgus
Glu22-Arg213
C-6His
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 54&51 KDa. Observed: (57-72)&(85-115) KDa, reducing conditions
Human
Ala27-Asp239&Leu23-Asn254
C-Fc&C-Fc
10 μg, 50 μg, 500 μg, 1 mg